SEC Comment Letter for BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818) (BPTH) — Nov 22, 2017
BIO-PATH HOLDINGS, INC. (BPTH) (CIK 0001133818)
Date: Nov. 22, 2017 · CIK: 0001133818 · Accession: 0000000000-17-041334
AI Filing Summary & Sentiment
Reasoning
Letter
November 22, 2017 Peter H. Nielsen President and Chief Executive Officer Bio-Path Holdings, Inc. 4710 Bellaire Boulevard, Suite 210 Bellaire, Texas 77401 Bio-Path Holdings, Inc. Registration Statement on Form S-3 Filed November 16, 2017 File No. 333-221610Re: Dear Mr. Nielsen: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Billy Rohrlich, Esq.
Show Raw Text
November 22, 2017
Peter H. Nielsen
President and Chief Executive Officer
Bio-Path Holdings, Inc.
4710 Bellaire Boulevard, Suite 210
Bellaire, Texas 77401
Bio-Path Holdings, Inc.
Registration Statement on Form S-3
Filed November 16, 2017
File No. 333-221610Re:
Dear Mr. Nielsen:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Billy Rohrlich, Esq.